PNPLA3 Risk Allele Association With ALT Response to Semaglutide Treatment.
作者信息
Urias Esteban, Tedesco Nicholas R, Oliveri Antonino, Raut Chinmay, Speliotes Elizabeth K, Chen Vincent L
机构信息
Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
出版信息
Gastroenterology. 2024 Mar;166(3):515-517.e2. doi: 10.1053/j.gastro.2023.11.018. Epub 2023 Nov 14.
Abstract
摘要
相似文献
1
PNPLA3 Risk Allele Association With ALT Response to Semaglutide Treatment.
Gastroenterology. 2024 Mar;166(3):515-517.e2. doi: 10.1053/j.gastro.2023.11.018. Epub 2023 Nov 14.
2
Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity.
Aliment Pharmacol Ther. 2019 Jul;50(2):193-203. doi: 10.1111/apt.15316. Epub 2019 Jun 10.
3
A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children.
J Pediatr. 2011 May;158(5):740-4. doi: 10.1016/j.jpeds.2010.11.016. Epub 2010 Dec 18.
4
Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis.
Medicine (Baltimore). 2019 Feb;98(7):e14324. doi: 10.1097/MD.0000000000014324.
5
African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population.
Ann Hepatol. 2022 Nov-Dec;27(6):100728. doi: 10.1016/j.aohep.2022.100728. Epub 2022 Jun 13.
6
A common variant in the peroxisome proliferator-activated receptor-γ coactivator-1α gene is associated with nonalcoholic fatty liver disease in obese children.
Am J Clin Nutr. 2013 Feb;97(2):326-31. doi: 10.3945/ajcn.112.046417. Epub 2012 Dec 26.
7
PNPLA3 Genotype and Diabetes Identify Patients With Nonalcoholic Fatty Liver Disease at High Risk of Incident Cirrhosis.
Gastroenterology. 2023 May;164(6):966-977.e17. doi: 10.1053/j.gastro.2023.01.040. Epub 2023 Feb 7.
8
A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.
J Hepatol. 2020 Jun;72(6):1070-1081. doi: 10.1016/j.jhep.2020.01.029. Epub 2020 Mar 5.
9
PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
Int J Mol Sci. 2016 Apr 27;17(5):630. doi: 10.3390/ijms17050630.
10
The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.
J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):69-74. doi: 10.1097/MPG.0000000000001979.
引用本文的文献
1
Meta-Analysis: Effects of Steatotic Liver Disease-Associated Genetic Risk Alleles on Longitudinal Outcomes.
Aliment Pharmacol Ther. 2025 Aug;62(3):244-276. doi: 10.1111/apt.70256. Epub 2025 Jun 28.
2
Human genetics of metabolic dysfunction-associated steatotic liver disease: from variants to cause to precision treatment.
J Clin Invest. 2025 Apr 1;135(7):e186424. doi: 10.1172/JCI186424.
3
Cracking the code of HBV persistence: cutting-edge approaches to targeting cccDNA in chronic hepatitis B with or without pyogenic liver Abscesses.
Front Med (Lausanne). 2025 Mar 17;12:1504736. doi: 10.3389/fmed.2025.1504736. eCollection 2025.
4
Global Epidemiology and Implications of I148M Variant in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-analysis.
J Clin Exp Hepatol. 2025 May-Jun;15(3):102495. doi: 10.1016/j.jceh.2024.102495. Epub 2024 Dec 26.
5
Recent advances in MASLD genetics: Insights into disease mechanisms and the next frontiers in clinical application.
Hepatol Commun. 2025 Jan 7;9(1). doi: 10.1097/HC9.0000000000000618. eCollection 2025 Jan 1.
6
Similar weight loss with semaglutide regardless of diabetes and cardiometabolic risk parameters in individuals with metabolic dysfunction-associated steatotic liver disease: Post hoc analysis of three randomised controlled trials.
Diabetes Obes Metab. 2025 Feb;27(2):710-718. doi: 10.1111/dom.16065. Epub 2024 Nov 28.
7
PNPLA3 I148M Interacts With Environmental Triggers to Cause Human Disease.
Liver Int. 2025 Mar;45(3):e16106. doi: 10.1111/liv.16106. Epub 2024 Nov 19.
8
The effect of dulaglutide on glycated hemoglobin is associated with PNPLA3 Ι148Μ gene polymorphism in patients with type 2 diabetes mellitus.
Endocrine. 2025 Jan;87(1):73-78. doi: 10.1007/s12020-024-04007-8. Epub 2024 Aug 23.
本文引用的文献
1
The Michigan Genomics Initiative: A biobank linking genotypes and electronic clinical records in Michigan Medicine patients.
Cell Genom. 2023 Jan 31;3(2):100257. doi: 10.1016/j.xgen.2023.100257. eCollection 2023 Feb 8.
2
PNPLA3 Genotype and Diabetes Identify Patients With Nonalcoholic Fatty Liver Disease at High Risk of Incident Cirrhosis.
Gastroenterology. 2023 May;164(6):966-977.e17. doi: 10.1053/j.gastro.2023.01.040. Epub 2023 Feb 7.
3
PNPLA3 I148M and response to treatment for hepatic steatosis: A systematic review.
Liver Int. 2023 May;43(5):975-988. doi: 10.1111/liv.15533. Epub 2023 Feb 16.
4
Clinical Utility of Combined MRI-PDFF and ALT Response in Predicting Histologic Response in Nonalcoholic Fatty Liver Disease.
Clin Gastroenterol Hepatol. 2023 Sep;21(10):2682-2685.e4. doi: 10.1016/j.cgh.2022.08.036. Epub 2022 Sep 6.
5
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease.
J Hepatol. 2022 Mar;76(3):526-535. doi: 10.1016/j.jhep.2021.10.013. Epub 2021 Oct 25.
6
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.
N Engl J Med. 2021 Mar 25;384(12):1113-1124. doi: 10.1056/NEJMoa2028395. Epub 2020 Nov 13.
7
Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis.
Gastroenterology. 2019 Jan;156(1):88-95.e5. doi: 10.1053/j.gastro.2018.09.021. Epub 2018 Sep 15.
8
Next-generation genotype imputation service and methods.
Nat Genet. 2016 Oct;48(10):1284-1287. doi: 10.1038/ng.3656. Epub 2016 Aug 29.
9
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study.
Lancet. 2016 Feb 13;387(10019):679-690. doi: 10.1016/S0140-6736(15)00803-X. Epub 2015 Nov 20.
Zotero 插件